nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0145	0.121	CcSEcCtD
Nimodipine—CACNB3—endometrium—polycystic ovary syndrome	0.0125	0.037	CbGeAlD
Nimodipine—CACNB4—vagina—polycystic ovary syndrome	0.0122	0.0362	CbGeAlD
Nimodipine—CACNB1—adipose tissue—polycystic ovary syndrome	0.0117	0.0348	CbGeAlD
Nimodipine—CACNB3—uterus—polycystic ovary syndrome	0.0115	0.0341	CbGeAlD
Nimodipine—CACNB3—pituitary gland—polycystic ovary syndrome	0.0113	0.0335	CbGeAlD
Nimodipine—CACNB3—adipose tissue—polycystic ovary syndrome	0.0113	0.0333	CbGeAlD
Nimodipine—CYP3A4—urine—polycystic ovary syndrome	0.0106	0.0313	CbGeAlD
Nimodipine—CACNB1—adrenal gland—polycystic ovary syndrome	0.0105	0.0312	CbGeAlD
Nimodipine—AHR—adrenal cortex—polycystic ovary syndrome	0.0104	0.0307	CbGeAlD
Nimodipine—CACNB3—adrenal gland—polycystic ovary syndrome	0.0101	0.0299	CbGeAlD
Nimodipine—CACNB1—female gonad—polycystic ovary syndrome	0.00982	0.0291	CbGeAlD
Nimodipine—CACNB3—female gonad—polycystic ovary syndrome	0.00942	0.0279	CbGeAlD
Nimodipine—CACNB3—vagina—polycystic ovary syndrome	0.00936	0.0277	CbGeAlD
Nimodipine—AHR—endometrium—polycystic ovary syndrome	0.00926	0.0274	CbGeAlD
Nimodipine—AHR—uterus—polycystic ovary syndrome	0.00853	0.0253	CbGeAlD
Nimodipine—AHR—pituitary gland—polycystic ovary syndrome	0.00838	0.0248	CbGeAlD
Nimodipine—AHR—adipose tissue—polycystic ovary syndrome	0.00834	0.0247	CbGeAlD
Nimodipine—CACNA1D—adrenal cortex—polycystic ovary syndrome	0.00822	0.0243	CbGeAlD
Nimodipine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00763	0.0639	CcSEcCtD
Nimodipine—CACNB2—pituitary gland—polycystic ovary syndrome	0.0076	0.0225	CbGeAlD
Nimodipine—AHR—adrenal gland—polycystic ovary syndrome	0.00748	0.0222	CbGeAlD
Nimodipine—AHR—female gonad—polycystic ovary syndrome	0.00698	0.0207	CbGeAlD
Nimodipine—AHR—vagina—polycystic ovary syndrome	0.00694	0.0205	CbGeAlD
Nimodipine—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00691	0.0204	CbGeAlD
Nimodipine—CACNB2—adrenal gland—polycystic ovary syndrome	0.00679	0.0201	CbGeAlD
Nimodipine—CACNA1D—pituitary gland—polycystic ovary syndrome	0.00664	0.0197	CbGeAlD
Nimodipine—AHR—endocrine gland—polycystic ovary syndrome	0.00649	0.0192	CbGeAlD
Nimodipine—CACNB2—vagina—polycystic ovary syndrome	0.00629	0.0186	CbGeAlD
Nimodipine—NR3C2—endometrium—polycystic ovary syndrome	0.00617	0.0183	CbGeAlD
Nimodipine—CACNA1C—pituitary gland—polycystic ovary syndrome	0.00613	0.0181	CbGeAlD
Nimodipine—CACNA1C—adipose tissue—polycystic ovary syndrome	0.00611	0.0181	CbGeAlD
Nimodipine—CACNA1D—adrenal gland—polycystic ovary syndrome	0.00593	0.0176	CbGeAlD
Nimodipine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00572	0.0479	CcSEcCtD
Nimodipine—NR3C2—uterus—polycystic ovary syndrome	0.00568	0.0168	CbGeAlD
Nimodipine—NR3C2—pituitary gland—polycystic ovary syndrome	0.00558	0.0165	CbGeAlD
Nimodipine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00558	0.0467	CcSEcCtD
Nimodipine—NR3C2—adipose tissue—polycystic ovary syndrome	0.00556	0.0165	CbGeAlD
Nimodipine—CACNA1C—adrenal gland—polycystic ovary syndrome	0.00548	0.0162	CbGeAlD
Nimodipine—Nicardipine—ADRA1D—polycystic ovary syndrome	0.00526	0.327	CrCbGaD
Nimodipine—Sweating increased—Metformin—polycystic ovary syndrome	0.00521	0.0436	CcSEcCtD
Nimodipine—CACNA1D—endocrine gland—polycystic ovary syndrome	0.00515	0.0152	CbGeAlD
Nimodipine—CACNA1C—vagina—polycystic ovary syndrome	0.00508	0.015	CbGeAlD
Nimodipine—NR3C2—adrenal gland—polycystic ovary syndrome	0.00499	0.0148	CbGeAlD
Nimodipine—CACNA1C—endocrine gland—polycystic ovary syndrome	0.00475	0.0141	CbGeAlD
Nimodipine—NR3C2—female gonad—polycystic ovary syndrome	0.00465	0.0138	CbGeAlD
Nimodipine—NR3C2—vagina—polycystic ovary syndrome	0.00462	0.0137	CbGeAlD
Nimodipine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00451	0.0378	CcSEcCtD
Nimodipine—Nicardipine—ADRA1B—polycystic ovary syndrome	0.00449	0.279	CrCbGaD
Nimodipine—Bradycardia—Metformin—polycystic ovary syndrome	0.00436	0.0365	CcSEcCtD
Nimodipine—NR3C2—endocrine gland—polycystic ovary syndrome	0.00432	0.0128	CbGeAlD
Nimodipine—Hepatitis—Metformin—polycystic ovary syndrome	0.00428	0.0359	CcSEcCtD
Nimodipine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00398	0.0333	CcSEcCtD
Nimodipine—Flushing—Metformin—polycystic ovary syndrome	0.00398	0.0333	CcSEcCtD
Nimodipine—Angiopathy—Metformin—polycystic ovary syndrome	0.00389	0.0325	CcSEcCtD
Nimodipine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00387	0.0324	CcSEcCtD
Nimodipine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00359	0.03	CcSEcCtD
Nimodipine—Palpitations—Metformin—polycystic ovary syndrome	0.0033	0.0276	CcSEcCtD
Nimodipine—Hypertension—Metformin—polycystic ovary syndrome	0.00322	0.027	CcSEcCtD
Nimodipine—Myalgia—Metformin—polycystic ovary syndrome	0.00318	0.0266	CcSEcCtD
Nimodipine—Oedema—Metformin—polycystic ovary syndrome	0.00304	0.0255	CcSEcCtD
Nimodipine—Nicardipine—ADRA1A—polycystic ovary syndrome	0.00302	0.188	CrCbGaD
Nimodipine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.003	0.00889	CbGeAlD
Nimodipine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00298	0.025	CcSEcCtD
Nimodipine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00298	0.0249	CcSEcCtD
Nimodipine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00294	0.0246	CcSEcCtD
Nimodipine—Hypotension—Metformin—polycystic ovary syndrome	0.00284	0.0238	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00277	0.0232	CcSEcCtD
Nimodipine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00271	0.0227	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00263	0.022	CcSEcCtD
Nimodipine—CYP3A5—female gonad—polycystic ovary syndrome	0.00251	0.00744	CbGeAlD
Nimodipine—CYP3A5—vagina—polycystic ovary syndrome	0.0025	0.00739	CbGeAlD
Nimodipine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00234	0.00692	CbGeAlD
Nimodipine—Pruritus—Metformin—polycystic ovary syndrome	0.00215	0.018	CcSEcCtD
Nimodipine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00208	0.0174	CcSEcCtD
Nimodipine—Dizziness—Metformin—polycystic ovary syndrome	0.00201	0.0169	CcSEcCtD
Nimodipine—Vomiting—Metformin—polycystic ovary syndrome	0.00194	0.0162	CcSEcCtD
Nimodipine—Rash—Metformin—polycystic ovary syndrome	0.00192	0.0161	CcSEcCtD
Nimodipine—Dermatitis—Metformin—polycystic ovary syndrome	0.00192	0.0161	CcSEcCtD
Nimodipine—Headache—Metformin—polycystic ovary syndrome	0.00191	0.016	CcSEcCtD
Nimodipine—Nausea—Metformin—polycystic ovary syndrome	0.00181	0.0151	CcSEcCtD
Nimodipine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00175	0.00519	CbGeAlD
Nimodipine—Amlodipine—CYP1A1—polycystic ovary syndrome	0.00175	0.109	CrCbGaD
Nimodipine—Nifedipine—CYP1A1—polycystic ovary syndrome	0.00156	0.0973	CrCbGaD
Nimodipine—CACNB2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000334	0.000634	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PPARG—polycystic ovary syndrome	0.000333	0.000633	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C2—polycystic ovary syndrome	0.000331	0.000629	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TEAD2—polycystic ovary syndrome	0.000331	0.000629	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000331	0.000629	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—INS—polycystic ovary syndrome	0.000327	0.000621	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PPARG—polycystic ovary syndrome	0.000324	0.000615	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000324	0.000615	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—RRM2—polycystic ovary syndrome	0.000323	0.000614	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—INS—polycystic ovary syndrome	0.000318	0.000604	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000318	0.000603	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000317	0.000602	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000316	0.000601	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000316	0.000601	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PNPLA2—polycystic ovary syndrome	0.000316	0.0006	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT2—polycystic ovary syndrome	0.000316	0.0006	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—DLG4—polycystic ovary syndrome	0.000315	0.000599	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PGR—polycystic ovary syndrome	0.000314	0.000596	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000313	0.000594	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—YAP1—polycystic ovary syndrome	0.000312	0.000592	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000309	0.000587	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000308	0.000585	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT2—polycystic ovary syndrome	0.000307	0.000583	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000305	0.000579	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—STAR—polycystic ovary syndrome	0.000302	0.000573	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SRD5A1—polycystic ovary syndrome	0.0003	0.000569	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NAMPT—polycystic ovary syndrome	0.000299	0.000568	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000297	0.000563	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000296	0.000561	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000296	0.000561	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—polycystic ovary syndrome	0.000289	0.000549	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000286	0.000544	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000286	0.000543	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—STAR—polycystic ovary syndrome	0.000286	0.000543	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000284	0.000539	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000282	0.000536	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—polycystic ovary syndrome	0.000281	0.000534	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000279	0.00053	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PNPLA2—polycystic ovary syndrome	0.000278	0.000527	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000275	0.000522	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—LEP—polycystic ovary syndrome	0.000273	0.000518	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HMMR—polycystic ovary syndrome	0.000269	0.000511	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000269	0.000511	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SRD5A1—polycystic ovary syndrome	0.000263	0.0005	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000258	0.00049	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000257	0.000487	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMMR—polycystic ovary syndrome	0.000255	0.000484	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—STAR—polycystic ovary syndrome	0.000251	0.000477	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00025	0.000476	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—polycystic ovary syndrome	0.00025	0.000475	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000249	0.000473	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000246	0.000467	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AR—polycystic ovary syndrome	0.000244	0.000464	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HSD3B1—polycystic ovary syndrome	0.000243	0.000461	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TH—polycystic ovary syndrome	0.000238	0.000452	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PPARG—polycystic ovary syndrome	0.000237	0.000451	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000236	0.000449	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—LHB—polycystic ovary syndrome	0.000234	0.000444	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—LEP—polycystic ovary syndrome	0.000234	0.000444	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—INS—polycystic ovary syndrome	0.000233	0.000442	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000231	0.000439	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000231	0.000438	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000229	0.000434	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000227	0.000432	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT2—polycystic ovary syndrome	0.000225	0.000427	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMMR—polycystic ovary syndrome	0.000224	0.000425	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—LHB—polycystic ovary syndrome	0.000222	0.000421	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000222	0.000421	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—LEP—polycystic ovary syndrome	0.000221	0.00042	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000219	0.000415	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000217	0.000413	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HSD3B2—polycystic ovary syndrome	0.000217	0.000411	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HSD3B1—polycystic ovary syndrome	0.000214	0.000405	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NCOR1—polycystic ovary syndrome	0.000213	0.000405	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1C1—polycystic ovary syndrome	0.00021	0.000398	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000206	0.000392	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—polycystic ovary syndrome	0.000206	0.000391	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000204	0.000388	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000204	0.000387	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PPARG—polycystic ovary syndrome	0.000204	0.000387	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000203	0.000385	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000202	0.000383	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000201	0.000382	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000201	0.000381	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—polycystic ovary syndrome	0.0002	0.00038	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—INS—polycystic ovary syndrome	0.0002	0.000379	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NR3C1—polycystic ovary syndrome	0.000198	0.000375	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RRM2—polycystic ovary syndrome	0.000197	0.000375	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—LHB—polycystic ovary syndrome	0.000195	0.00037	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—polycystic ovary syndrome	0.000195	0.00037	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—LEP—polycystic ovary syndrome	0.000194	0.000369	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GNAS—polycystic ovary syndrome	0.000194	0.000369	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SULT2A1—polycystic ovary syndrome	0.000193	0.000367	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT2—polycystic ovary syndrome	0.000193	0.000366	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PPARG—polycystic ovary syndrome	0.000193	0.000366	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HSD3B2—polycystic ovary syndrome	0.00019	0.000361	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—YAP1—polycystic ovary syndrome	0.00019	0.000361	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—INS—polycystic ovary syndrome	0.000189	0.000359	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RRM2—polycystic ovary syndrome	0.000187	0.000355	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000186	0.000353	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000186	0.000352	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000186	0.000352	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NCOR1—polycystic ovary syndrome	0.000185	0.000351	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C1—polycystic ovary syndrome	0.000184	0.00035	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NAMPT—polycystic ovary syndrome	0.000183	0.000347	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT2—polycystic ovary syndrome	0.000183	0.000347	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000181	0.000343	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000181	0.000343	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—YAP1—polycystic ovary syndrome	0.00018	0.000342	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—polycystic ovary syndrome	0.000179	0.000339	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000178	0.000339	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—polycystic ovary syndrome	0.000177	0.000336	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000175	0.000333	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NAMPT—polycystic ovary syndrome	0.000173	0.000329	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000172	0.000328	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000172	0.000327	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP11A1—polycystic ovary syndrome	0.000171	0.000325	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000171	0.000324	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SULT2A1—polycystic ovary syndrome	0.00017	0.000322	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—polycystic ovary syndrome	0.000169	0.000322	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000168	0.00032	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000168	0.000319	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000168	0.000319	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—polycystic ovary syndrome	0.000167	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—INS—polycystic ovary syndrome	0.000166	0.000315	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000166	0.000315	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RRM2—polycystic ovary syndrome	0.000164	0.000312	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—polycystic ovary syndrome	0.000163	0.00031	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1C3—polycystic ovary syndrome	0.000161	0.000307	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT2—polycystic ovary syndrome	0.000161	0.000305	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP17A1—polycystic ovary syndrome	0.000159	0.000302	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—YAP1—polycystic ovary syndrome	0.000158	0.000301	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	0.000153	0.000291	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NAMPT—polycystic ovary syndrome	0.000152	0.000289	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00015	0.000286	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP11A1—polycystic ovary syndrome	0.00015	0.000285	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000147	0.000279	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—polycystic ovary syndrome	0.000147	0.000279	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000147	0.000279	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000147	0.000279	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TH—polycystic ovary syndrome	0.000145	0.000276	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—polycystic ovary syndrome	0.000143	0.000271	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—polycystic ovary syndrome	0.000143	0.000271	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C3—polycystic ovary syndrome	0.000142	0.000269	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000141	0.000268	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP17A1—polycystic ovary syndrome	0.00014	0.000265	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—polycystic ovary syndrome	0.000139	0.000264	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000138	0.000262	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TH—polycystic ovary syndrome	0.000138	0.000261	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC2A4—polycystic ovary syndrome	0.000134	0.000254	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000133	0.000253	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000133	0.000252	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—polycystic ovary syndrome	0.000133	0.000252	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000131	0.000249	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POMC—polycystic ovary syndrome	0.000131	0.000248	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—INS—polycystic ovary syndrome	0.00013	0.000247	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000126	0.000239	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP19A1—polycystic ovary syndrome	0.000126	0.000239	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000123	0.000233	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—polycystic ovary syndrome	0.000122	0.000232	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TH—polycystic ovary syndrome	0.000121	0.00023	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000119	0.000227	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNAS—polycystic ovary syndrome	0.000119	0.000225	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC2A4—polycystic ovary syndrome	0.000118	0.000223	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000117	0.000221	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—polycystic ovary syndrome	0.000116	0.00022	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NCOR1—polycystic ovary syndrome	0.000113	0.000215	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNAS—polycystic ovary syndrome	0.000112	0.000213	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000111	0.000211	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP19A1—polycystic ovary syndrome	0.000111	0.00021	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000107	0.000204	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000107	0.000203	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NCOR1—polycystic ovary syndrome	0.000107	0.000203	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000106	0.000201	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000105	0.000199	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—polycystic ovary syndrome	0.000102	0.000193	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—polycystic ovary syndrome	0.000102	0.000193	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—polycystic ovary syndrome	0.000101	0.000193	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—polycystic ovary syndrome	9.98e-05	0.00019	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	9.91e-05	0.000188	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNAS—polycystic ovary syndrome	9.87e-05	0.000187	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—polycystic ovary syndrome	9.45e-05	0.00018	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	9.45e-05	0.000179	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	9.43e-05	0.000179	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NCOR1—polycystic ovary syndrome	9.4e-05	0.000178	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—polycystic ovary syndrome	8.91e-05	0.000169	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—polycystic ovary syndrome	8.72e-05	0.000166	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.63e-05	0.000164	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.63e-05	0.000164	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	8.62e-05	0.000164	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	8.42e-05	0.00016	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—polycystic ovary syndrome	8.31e-05	0.000158	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—polycystic ovary syndrome	8.26e-05	0.000157	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	8.16e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—polycystic ovary syndrome	8.1e-05	0.000154	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.02e-05	0.000152	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.99e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POMC—polycystic ovary syndrome	7.98e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—INS—polycystic ovary syndrome	7.94e-05	0.000151	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—polycystic ovary syndrome	7.67e-05	0.000146	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POMC—polycystic ovary syndrome	7.56e-05	0.000144	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—INS—polycystic ovary syndrome	7.52e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	7.51e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	7.27e-05	0.000138	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—polycystic ovary syndrome	7.26e-05	0.000138	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	7.01e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.82e-05	0.000129	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.82e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—polycystic ovary syndrome	6.74e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	6.73e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	6.65e-05	0.000126	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POMC—polycystic ovary syndrome	6.64e-05	0.000126	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—INS—polycystic ovary syndrome	6.61e-05	0.000125	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	6.28e-05	0.000119	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	6.18e-05	0.000117	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.71e-05	0.000109	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.42e-05	0.000103	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.35e-05	0.000102	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.2e-05	9.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.17e-05	9.81e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.89e-05	9.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.61e-05	8.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.39e-05	8.34e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.37e-05	8.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.16e-05	7.9e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.01e-05	7.61e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.94e-05	7.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.92e-05	7.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.79e-05	7.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.68e-05	6.98e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.49e-05	6.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.38e-05	6.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.26e-05	6.19e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.13e-05	5.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.09e-05	5.87e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.98e-05	5.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.94e-05	5.58e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.92e-05	5.55e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.92e-05	5.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.87e-05	5.46e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.49e-05	4.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.42e-05	4.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.27e-05	4.32e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.03e-05	3.86e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.93e-05	3.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.83e-05	3.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.71e-05	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.39e-05	2.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.37e-05	2.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.36e-05	2.58e-05	CbGpPWpGaD
